Best oncology and hematology podcasts we could find (Updated June 2017)
Related podcasts: Cancer Oncology Hematology Medical Education Science Medicine Breast Haematology Peervoice Cne Ce Inreview Insession Peerview Press Cme Credits Continuing Medical Education Cme Integrative Oncology Renal Cell Renal  
Oncology and hematology public [search 0]
show episodes
 
P
PeerView Press Oncology & Hematology CME/CNE/CPE Audio Podcast
 
PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
 
P
PeerView Oncology & Hematology CME/CNE/CPE Video Podcast
 
PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
 
P
PeerVoice Oncology & Haematology Audio
 
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
 
P
PeerVoice Oncology & Haematology Video
 
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
 
L
Lung Cancer Update
Monthly
 
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.
 
B
Breast Cancer Update
Monthly
 
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.
 
T
This Week in Oncology
Monthly
 
This Week In Oncology (TWiO) is a broadcast series on Wednesdays at 2PM Pacific/5PM Eastern. Board Certified in Hematology, Oncology and Internal Medicine, Richard Just, MD, aka @chemosabe1 on Twitter, and Gregg Masters, MPH, aka @2healthguru, co-host the weekly broadcasts. The show focuses on health, wellness, social media, patient empowerment, health reform, clinical trials, and promise of evidence based medicine in the prevention, diagnosis and treatment of cancer.
 
R
Renal Cell Cancer Update
Rare
 
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in renal cell carcinoma.
 
O
Oncology Times - OT Broadcasts from the iPad Archives
 
Independent and targeted hematology/oncology news for cancer patient care team; breaking clinical news; oncology analysis and commentary; professional trends.
 
I
Imedex E-Learning (Audio)
Daily+
 
Imedex, LLC is an accredited provider of independent medical education dedicated to creating learning opportunities for physicians, nurses, and other healthcare professionals. Our audio podcasts include a range of formats such as interviews, case discussions, and presentations from renowned experts who discuss the latest research and clinically relevant information. Our activities focus on impacting the clinical management of patients in the therapy areas of oncology, hematology, gastroenter ...
 
Loading …
show series
 
Breaking the Barriers to Patient-Centric Pancreatic Cancer Care: Nurses Transforming Practice From the Front Lines
 
The American Cancer Society estimates that some 1-point-7 million new cases of cancer will be diagnosed in 2017. The chances for an American male developing cancer is almost 41 percent, while the chances for an American woman to develop cancer is over 37 percent. The good news is that the survival rates for all forms of cancer have jumped from ...…
 
While many people work to avoid a conversation about death, others choose to be surrounded by it every day. Maggie McMeekin is a Resource Nurse at a JourneyCare in-patient hospice clinic in the northwest suburbs. Morning Shift spends a day on the job with McMeekin to better understand her reality. We also hear from Dr. Jalal Baig, who spends hi ...…
 
Interdisciplinary Approaches to Personalizing Immunotherapy in Metastatic CRC Using Advances in Molecular Markers
 
Interdisciplinary Approaches to Personalizing Immunotherapy in Metastatic CRC Using Advances in Molecular Markers
 
N
Nightside With Dan Rea
 
There is nothing more frightening or intimidating than hearing your doctor use the word cancer. But as devastating as the diagnosis may feel, cancer is often not the death sentence it once was. Tonight, Dan is joined by Dr. David Ryan, chief of hematology/oncology at Massachusetts General Hospital, and Dr. Vicki Jackson, chief of palliative car ...…
 
New Concepts in Immunotherapy for Solid Tumors: Novel Immune Approaches, Biomarkers, & Immune-Based Combinations
 
New Concepts in Immunotherapy for Solid Tumors: Novel Immune Approaches, Biomarkers, & Immune-Based Combinations
 
Enhancing Autologous Hematopoietic Stem Cell Transplantation Through Individualized Stem Cell Mobilization Strategies
 
A
Ask The Expert - A BloodStream Media Podcast
 
In this episode Dr. Robert Sidonio, an Assistant Clinical Professor of Pediatrics at Emory University Hospital and the Clinical Director of Hemostasis/Thrombosis at the Children’s Hospital of Atlanta, answers questions on and about women with bleeding disorders. Dr. Sidonio is a leading expert in the treatment and management of women with bleed ...…
 
Using Innovative Therapy for B-Cell Malignancies: A Focus on Integrating Novel Agent Classes Into Care
 
Dr. Veronica Anderson, Host, Functional Medicine Specialist and Medical Intuitive interviews Dr. Kevin Ryan as they talk about surviving cancer, oncology and medical marijuana treatment. Have you or someone you love been diagnosed with cancer? Kevin P. Ryan, MD FACP COL USAF (ret ) graduated summa cum laude, Phi Beta Kappa from Georgetown Unive ...…
 
For a young cancer patient, the tools and medical devices in the UNC Hospitals' Pediatric Hematology–Oncology Clinic can be terrifying.But two UNC School of Medicine students are working to provide medical play kits to help the children better understand their surroundings and ease their fears as they're treated at the clinic.In this week's epi ...…
 
Need-to-Know Guidance for Navigating the Complex and Expanding Treatment Landscape in Prostate Cancer
 
Maximizing the Therapeutic Potential of Immune Checkpoint Blockade Across the Oncologic Spectrum: Guidance for Assessment of Response and Management of Immune-Related Adverse Effects
 
J
Journal of Oncology Practice Podcast
 
Dr. Robin Zon of Michiana Hematology and Oncology discusses the latest State of Cancer Care in America report, and the opportunities and challenges confronting the cancer care community.
 
E
Eye on Health on Dubai Today
 
Suzanne Radford is in with Dr. Pamela Munster, Professor of Hematology/Oncology, Director of the Early Phase Clinical Trials Program and Associate Director of Investigational Therapeutics at the University of California, San Francisco. She is also a visiting consultant at Zulekha Hospital.
 
Strengthening the Genetics-Hematology Partnership to Shorten the Path to Diagnosis & Treatment of Gaucher Disease Type 1: A Patient Story
 
Maximizing Patient Outcomes in Myelofibrosis: Stem Cell Transplantation in the JAK Inhibitor Era
 
Autologous Transplant in the Era of Novel Therapy in Myeloma: Using Innovative Concepts to Maximize Patient Outcomes
 
Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
 
Our immune system does an amazing job of protecting us from infections and even works naturally prevent cancer. . It has long been recognized that harnessing the immune system to treat cancer is a reasonable goal but efforts have not been stellar. It now appears that this is changing. On this edition of Line One Anchorage cancer specialist Dr. ...…
 
Maximizing Outcomes With Allogeneic HCT in AML: Insight on the Impact of Novel Therapy
 
A
ASCO University Weekly Podcasts
 
Davendra Sohal, MD, MPH, Assistant Professor of Hematology and Medical Oncology at the Cleveland Clinic, presents the ASCO Clinical Practice Guideline on metastatic pancreatic cancer, originally published in the Journal of Clinical Oncology in August 2016.
 
Recent years have seen the emergence of immunotherapy as a leading form of treatment for multiple myeloma. New strategies such as monoclonal antibody therapies. antibody-drug conjugates, immune checkpoint therapy, adoptive cell therapies such as natural killer cells, marrow infiltrating lymphocytes, dendritic cells, CAR T cell therapies and can ...…
 
Preventing and Managing Cytomegalovirus and Invasive Fungal Infection After Hematopoietic Stem Cell Transplantation: Key Questions, Expert Answers
 
Evan Goldberg, Executive Vice President of Development, Oracle NetSuite Global Business Unit; Founder, BRCA Foundation Alan Ashworth, Ph.D., FRS, President, UCSF Helen Diller Family Comprehensive Cancer Center; Senior Vice President for Cancer Services, UCSF Health; Professor of Medicine, Division of Hematology/Oncology, Department of Medicine, ...…
 
Evan Goldberg, Executive Vice President of Development, Oracle NetSuite Global Business Unit; Founder, BRCA Foundation Alan Ashworth, Ph.D., FRS, President, UCSF Helen Diller Family Comprehensive Cancer Center; Senior Vice President for Cancer Services, UCSF Health; Professor of Medicine, Division of Hematology/Oncology, Department of Medicine, ...…
 
Exploring Evolving Strategies for the Treatment of Patients With Triple-Negative Breast Cancer
 
Dr. Philip Lammers, a medical oncologist, is the chief of the Division of Hematology/Oncology at Meharry Medical College and adjunct assistant professor of internal medicine at Vanderbilt University. He has several active research projects on ways to increase minority and underserved population representation in clinical trials. He also studies ...…
 
Taking the Leap Into a New Era of Anti-Tumor Efficacy in Advanced RCC: How to Optimize Selection and Sequencing of Therapies Throughout the Disease Continuum
 
Filling the Void in Bladder Cancer: How Immune Checkpoint Inhibition Advances Our Understanding of Disease Biology and Therapy
 
T
The Premed Years | Medical School Headquarters | MCAT | AMCAS | Interviews
 
Session 226 The journey to medical school is long, tough, defeating, and can be isolating. There are plenty of news stories of physicians out there about job dissatisfaction, suicide rates, and suicides of medical students. Inevitably, there comes a lot of doubt when you're on this journey and you’re probably still thinking if this is what you ...…
 
D
Digital Health Today | Featuring the leading innovators and innovations reshaping healthcare
 
My guest today is none other than Dr Daniel Kraft; a physician-scientist, inventor, entrepreneur, and innovator. He has over 25 years experience working across health care innovation, biomedical research, and clinical practice. He is the Chair for Medicine at Singularity University and the Founder and Chair of Exponential Medicine, and we dive ...…
 
T
The Undifferentiated Medical Student
 
Help Ian interview all 120+ specialties by referring him physicians; or, if you're a physician, volunteer for an interview! Show notes page! Dr. Jalal is an Assistant Professor of Clinical Medicine at Indiana University School of Medicine. Dr. Jalal completed her medical degree at the University of Jordan Faculty of Medicine in 2002 and her res ...…
 
Technological Solutions For Global Hematology And Oncology by Blood Advances Talks
 
Exploring the Brave New World of Innovative Therapeutics in Hematologic Cancers: Updates From San Diego
 
D
Dawn Farm Addiction and Recovery Education Series
 
“How To Support Recovery and Not Support Addiction” was presented on January 24, 2017, by Dr. Charles F. Gehrke, MD, FACP, FASAM. The course of an individual’s substance use may be strongly influenced by family members, friends, employers and others. The disease of addiction is often poorly understood, and the behaviors of a person with addicti ...…
 
On this weeks show, Accelerating precision medicine for cancer patients, Avivagen partners with NRC to tackle antibiotic resistance in humans, and Knight buys in on an Israeli biotech, We have all this and more on this week’s Biotechnology Focus Radio Show Podcast. Welcome to another episode of Biotechnology Focus Podcast. I’m your host Shawn L ...…
 
Expert Discussions on Antibody-Based Therapy in AML: Will New Technologies Make a Difference in Patient Care?
 
Expert Discussions on Antibody-Based Therapy in AML: Will New Technologies Make a Difference in Patient Care?
 
Please join us this Wednesday, February 1, 2017 at 4:00 p.m. PST and 7:00 p.m. EST for a live show with host Denise Messenger. Our guest is Dr. Kevin Ryan. Dr. Kevin P. Ryan, MD, MBA, FACP is a cancer doctor, cancer survivor and author of “When Tumor is the Rumor and Cancer is the Answer: A comprehensive text for newly diagnosed cancer patients ...…
 
Gerald Woods, MD, Division Director of Hematology/Oncology/BMT, has more than 30 years experience in sickle cell treatment. Dr. Woods is currently a PI for a study of GBT-440, a new drug to treat sickle cell. Children’s Mercy is one of only two U.S. hospitals initially invited to participate in this research. Dr. Woods is leading the hospital’s ...…
 
The treatment options for myeloma continued to evolve in 2016 with new agents, immune based therapies and repurposing of existing approved agents. High-dose therapy and autologous stem cell transplantation continue to remain a backbone of upfront treatment in myeloma. We are talking to Dr. Ravi Vij, about the evolution of myeloma treatments in ...…
 
What does the beginning of breast cancer look like? What happens – at the very start – that turns normal breast tissue into the first stages of cancer? And by recognizing these early molecular changes and pathway alterations, could we not only improve our understanding of the evolution of breast cancer… but also, one would hope, find a way to s ...…
 
Treatment Evolution in Acute Lymphoblastic Leukemia: Insight on Novel Antibody Technologies and Immunotherapy Advances
 
Treatment Evolution in Acute Lymphoblastic Leukemia: Insight on Novel Antibody Technologies and Immunotherapy Advances
 
Speed
Series preference
1x
1x
Volume
100%
/

Google login Twitter login Classic login